Prognostic value of p53 in non-small cell lung cancer: Relationship with proliferating cell nuclear antigen and cigarette smoking

This publication has 16 references indexed in Scilit:

• Immunohistochemical detection of p53 protein is not associated with a poor prognosis in non-small-cell lung cancer
  The Journal of Thoracic and Cardiovascular Surgery, 1995
• Comparative analysis of p53 gene mutations and protein accumulation in human non‐small‐cell lung cancer
  International Journal of Cancer, 1995
• Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopathological factors in breast cancer
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1995
• p53 in Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1994
• Proliferation in malignant mesothelioma as determined by mitosis counts and immunoreactivity for proliferating cell nuclear antigen (PCNA)
  The Journal of Pathology, 1994
• THE TUMOR SUPPRESSOR GENES
  Annual Review of Biochemistry, 1993
• Smoking-Attributable Cancer Mortality in 1991: Is Lung Cancer Now the Leading Cause of Death Among Smokers in the United States?
  JNCI Journal of the National Cancer Institute, 1991
• p53 Mutations in Human Cancers
  Science, 1991
• Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms
  The Journal of Pathology, 1990
• Increased expression of mutant forms of p53 oncogene in primary lung cancer
  The Lancet, 1990